Written Question·Department of Health and Social Care·UIN 1890

Pancreatin

Tabled: 25 July 2024
Answered: 5 August 2024

Question

Peter Swallow

LabourBracknell

To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of the availability of Creon to treat Type 2 diabetes.

Answer

Karin Smyth
The Department has been working with suppliers to address current supply issues with pancreatic enzyme replacement therapy (PERT), including Creon, used by patients with conditions such as type 2 diabetes, cystic fibrosis, and certain cancers, including p...

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 1890) →